EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

YAP1 lactylation confers cisplatin resistance and prognostic value by suppressing ferroptosis via FOSL1 in bladder cancer

Zheyu Ai, Hao Zhou, Lijuan Jiang, Yuejiao Lang, Zihao Feng, Ziran Dai, Haoqian Feng, Zhenwei Li, Hansen Lin, Jun Lu, Gaowei Huang, Jinchen Luo und 7 weitere

Cell Reports · 2026-07 · 45 (7) · 117692

DOI: 10.1016/j.celrep.2026.117692 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2026-07. Verfasst von Zheyu Ai und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510000, China. Hauptthemen laut MEDLINE: Cisplatin, Urinary Bladder Neoplasms, Drug Resistance, Neoplasm, Adaptor Proteins, Signal Transducing. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Guangzhou Science and Technology Program Key Projects.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Resistance to cisplatin-based chemotherapy remains a major barrier to effective systemic treatment of bladder cancer, underscoring the need for predictive biomarkers and therapeutic targets. Here, we identify YAP1-K90la as a functional post-translational modification that causally drives cisplatin resistance. Across multi-center clinical cohorts, elevated YAP1-K90la levels were associated with poor therapeutic outcomes and outperformed total YAP1 expression in predicting cisplatin responsiveness. Mechanistically, YAP1-K90la enhances YAP1 nuclear localization and transcriptional activity to induce a FOSL1-dependent program that suppresses ferroptosis and promotes cell survival under cisplatin stress. Notably, AARS1 and SIRT1 function as the "writer" and "eraser" of YAP1-K90la, respectively, with SMURF2-mediated ubiquitination of SIRT1 stabilizing YAP1-K90la and driving resistance. Targeting YAP1-K90la using a cell-penetrating peptide restored ferroptotic vulnerability and sensitized bladder cancer cells to cisplatin. Collectively, these findings reveal the YAP1-K90la/FOSL1 pathway that drives cisplatin resistance and position YAP1-K90la as a clinically actionable biomarker and therapeutic target in bladder cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinUrinary Bladder NeoplasmsDrug Resistance, NeoplasmAdaptor Proteins, Signal TransducingProto-Oncogene Proteins c-fosTranscription FactorsFerroptosisHumansYAP-Signaling ProteinsCell Line, TumorFos-Related Antigen 1AnimalsPrognosisUbiquitinationAntineoplastic Agents

Stichwörter der Autor:innen

CP: cancerCP: metabolismYAP1bladder cancercisplatin resistanceferroptosislactylation

Substanzen

CisplatinYAP-Signaling ProteinsAdaptor Proteins, Signal TransducingYAP1 protein, humanProto-Oncogene Proteins c-fosFos-Related Antigen 1Transcription FactorsAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Urology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510000, China.
  • Department of Urology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
  • Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510000, China.
  • Department of Urology, Shenzhen People's Hospital, The Second Clinical Medical College of Jinan University, The First Affiliated Hospital of Southern University of Science and Technology, Shenzhen 518020, China.
  • Department of Urology, Yangjiang People's Hospital, Yangjiang 529500, China. Electronic address: yjhejingwei@163.com.
  • Department of Urology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510000, China. Electronic address: yuanz6@mail.sysu.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Guangzhou Science and Technology Program Key Projects

Zitieren

APA

Ai, Z., Zhou, H., Jiang, L., Lang, Y., Feng, Z., Dai, Z., Feng, H., Li, Z., Lin, H., Lu, J., Huang, G., Luo, J., Wei, J., Chen, W., Luo, J., He, J., Yu, A., Jin, X., & Chen, Z. (2026). YAP1 lactylation confers cisplatin resistance and prognostic value by suppressing ferroptosis via FOSL1 in bladder cancer. Cell Reports, 45(7), 117692. https://doi.org/10.1016/j.celrep.2026.117692

Vancouver

Ai Z, Zhou H, Jiang L, Lang Y, Feng Z, Dai Z, et al. YAP1 lactylation confers cisplatin resistance and prognostic value by suppressing ferroptosis via FOSL1 in bladder cancer. Cell Reports. 2026;45(7):117692. doi:10.1016/j.celrep.2026.117692

BibTeX
@article{Ai2026,
  author = {Ai, Zheyu and Zhou, Hao and Jiang, Lijuan and Lang, Yuejiao and Feng, Zihao and Dai, Ziran and Feng, Haoqian and Li, Zhenwei and Lin, Hansen and Lu, Jun and Huang, Gaowei and Luo, Jinchen and Wei, Jinhuan and Chen, Wei and Luo, Junhang and He, Jingwei and Yu, Anze and Jin, Xiaohan and Chen, Zhenhua},
  title = {YAP1 lactylation confers cisplatin resistance and prognostic value by suppressing ferroptosis via FOSL1 in bladder cancer},
  journal = {Cell Reports},
  year = {2026},
  volume = {45},
  number = {7},
  pages = {117692},
  doi = {10.1016/j.celrep.2026.117692}
}
Kostenlos starten →